Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$353,080
+$24,104 QoQ
Shares Held
1,261
+2.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#660
of 1,046 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FRONTIER CAPITAL MANAGEMENT CO LLC holds $144,413,741 across 8 Diagnostics & Research names. LH ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
173,547 | $47,109,333 | |
| 2 | RVTY |
Revvity, Inc.
|
180,771 | $20,112,581 | |
| 3 | ICLR |
Icon PLC
|
104,335 | $18,124,032 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
33,592 | $17,684,172 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
12,655 | $16,166,889 | |
| 6 | A |
Agilent Technologies, Inc.
|
100,214 | $13,311,425 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
50,938 | $11,552,229 | |
| 8 | LH |
Labcorp Holdings Inc.
This page
|
1,261 | $353,080 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $353,080 | 1,261 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $328,976 | 1,233 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $309,335 | 1,233 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $400,735 | 1,396 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $369,876 | 1,409 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $327,930 | 1,409 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $318,754 | 1,390 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $283,372 | 1,268 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $258,864 | 1,272 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||